Treatments that included anti-EGFR medication (Cetuximab/Panitumumab) revealed a similar age-related aspect for patients without diabetes and a bell-shaped curve for patients with DM, without indicating statistically significant correlations by age (Table 2, Figure 6). Here, EGFR is linked to diabetes mellitus.